2016 05 Mar
Over the past 25 years, gadolinium-based contrast agents (GBCA) have been recognised to have exceptional safety profiles with minimal side effects, as three researchers showed in their presentations at the European Congress of Radiology (ECR 2016) in Vienna. Dr. Richard Semelka of the Department of Radiology, University of North Carolina at Chapel... Read more
JOIN OUR MANAGEMENT COMMUNITY
Prof Elizabeth Teisberg to open the World Hospital Congress
Prof Elizabeth Teisberg, author of Redefining Health Care: Creating Va... Read more
Sectra wins US PACS order at pediatric orthopedic hospital
International medical imaging IT and cybersecurity company Sectra will... Read more
Masimo SET® Pulse Oximetry Helps Form Basis Of Utah Senate Resolution
The Utah State Legislature and Governor Gary Herbert have recentl Read more
Philips Speeds Up Research and Biomarker Discovery with Major Upgrade
Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health techno... Read more
Clinical Trials Demonstrate Benefits of iFR Compared to FFR
The DEFINE FLAIR and iFR Swedeheart studies establish that iFR offers a... Read more
HANJ Recognizes CSL CEO Paul Perreault as “Humanitarian Man of the Year”
HANJ President David Lechner presented the award to Perreault at the a... Read more
Geraldine McGinty to Receive Thorwarth Award for Radiology Leadership
The American College of Radiology selected Geraldine McGinty, MD, MBA,... Read more
Belintra strengthens its management team with two new partners
Kris Liesmons and Dirk Deruytere joined Belintra as managing partners and... Read more
John Ormiston Awarded the EuroPCR 2017 Ethica Award
The 2017 Ethica Award, the highest honour of the European cardiovascular... Read more
New President of Sectra’s Secure Communications Business Area
Simo Pykälistö, currently CFO and Executive Vice President of Sectra AB... Read more
JOIN OUR MANAGEMENT COMMUNITY
JOIN OUR MANAGEMENT COMMUNITY